Literature DB >> 19647138

Clinical manifestations and diagnosis of fibromyalgia.

Robert M Bennett1.   

Abstract

Since the publication of the American College of Rheumatology Classification Criteria for Fibromyalgia 18 years ago, there have been an ever-increasing number of research articles and reviews. From the National Library of Medicine alone there are more than 10,000 articles related to fibromyalgia. The major clinical manifestations of fibromyalgia have not changed, but their prevalence, associations, relative importance to the patient, and scientific underpinnings are increasingly better understood. This article provides an update on fibromyalgia symptomatology and looks at issues that need to be considered in the development of updated diagnostic guidelines. There is still no gold standard for making a diagnosis of fibromyalgia, but there is an increasing consensus for the development of new guidelines for diagnosis that modifies the currently proscribed tender point evaluation.

Entities:  

Mesh:

Year:  2009        PMID: 19647138     DOI: 10.1016/j.rdc.2009.05.009

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  29 in total

1.  Diagnostic uncertainty and epistemologic humility.

Authors:  Andrew Kelly; Richard S Panush
Journal:  Clin Rheumatol       Date:  2017-04-22       Impact factor: 2.980

Review 2.  Meta-analysis of cognitive performance in fibromyalgia.

Authors:  Tyler Bell; Zina Trost; Melissa T Buelow; Olivio Clay; Jarred Younger; David Moore; Michael Crowe
Journal:  J Clin Exp Neuropsychol       Date:  2018-02-01       Impact factor: 2.475

3.  Trauma-induced adiposis dolorosa (Dercum's disease).

Authors:  David Hao; Akintomi Olugbodi; Nneka Udechukwu; Anthony A Donato
Journal:  BMJ Case Rep       Date:  2018-03-28

Review 4.  An insight into the gastrointestinal component of fibromyalgia: clinical manifestations and potential underlying mechanisms.

Authors:  Mahmoud Slim; Elena Pita Calandre; Fernando Rico-Villademoros
Journal:  Rheumatol Int       Date:  2014-08-14       Impact factor: 2.631

5.  Individuals with fibromyalgia and depression: findings from a nationally representative Canadian survey.

Authors:  Esme Fuller-Thomson; Jodie Nimigon-Young; Sarah Brennenstuhl
Journal:  Rheumatol Int       Date:  2011-01-08       Impact factor: 2.631

6.  Milnacipran: a selective serotonin and norepinephrine dual reuptake inhibitor for the management of fibromyalgia.

Authors:  Robert H Palmer; Antonia Periclou; Pradeep Banerjee
Journal:  Ther Adv Musculoskelet Dis       Date:  2010-08       Impact factor: 5.346

7.  Functional Deficits in Mice Expressing Human Interleukin 8.

Authors:  Julie Michelle Brent; Zuozhen Tian; Lutian Yao; Jian Huang; Dessislava Z Markova; Frances S Shofer; Angela K Brice; Ling Qin; Carla R Scanzello; Flavia Vitale; Di Chen; Yejia Zhang
Journal:  Comp Med       Date:  2020-04-20       Impact factor: 0.982

8.  Milnacipran combined with pregabalin in fibromyalgia: a randomized, open-label study evaluating the safety and efficacy of adding milnacipran in patients with incomplete response to pregabalin.

Authors:  Philip J Mease; Mildred V Farmer; Robert H Palmer; R Michael Gendreau; Joel M Trugman; Yong Wang
Journal:  Ther Adv Musculoskelet Dis       Date:  2013-06       Impact factor: 5.346

9.  Effects of milnacipran on neurocognition, pain, and fatigue in fibromyalgia: a 13-week, randomized, placebo-controlled, crossover trial.

Authors:  Jeong Lan Kim; Shilpa Rele; David M Marks; Prakash S Masand; Pallavi Yerramsetty; Robert A Millet; Richard S Keefe; Ashwin A Patkar
Journal:  Prim Care Companion CNS Disord       Date:  2014-12-26

10.  Role and rationale for the use of milnacipran in the management of fibromyalgia.

Authors:  Jay D Kranzler; R Michael Gendreau
Journal:  Neuropsychiatr Dis Treat       Date:  2010-05-25       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.